SYK and osteoporosis: The revelation of glucocorticoid receptors and RANKL’s collaboration in instigating the SYK/SHP2/NF-κB signaling nexus thus potentiating osteoclast genesis, unveils fresh vantages on the mechanisms whereby glucocorticoids promote osteoporosis.